Tag:
AI
DeFi
Artificial Intelligence Presents an Underestimated Opportunity to Catalyze Digital Asset Adoption
The convergence of artificial intelligence and blockchain technology represents one of the most compelling, yet perhaps least understood, narratives poised to reshape the digital...
DeFi
AI agents now deliver compliance alerts directly to crypto exchanges and banks without human review delays
The landscape of regulatory compliance in digital assets is undergoing a fundamental shift as artificial intelligence begins to replace traditional analyst workflows. Blockworks has...
DeFi
Chinese AI companies reject US delegation over sanction fears
Amid escalating US China tech tensions, a delegation of American officials seeking dialogue with leading Chinese artificial intelligence firms was turned away this week....
NFTs
Micron Secures Memory Supply to Stabilize NFT Infrastructure Amid AI Demand
As the NFT market expands, the need for reliable high‑performance memory has never been clearer. Micron Technology, a leading semiconductor supplier, is stepping up...
NFTs
HIVE’s Paraguay GPUs Deliver H100 Level Performance and Drive a 22 Percent Stock Surge
HIVE Technologies has announced a breakthrough that could reshape the economics of artificial intelligence infrastructure. By deploying a network of high‑performance GPUs in Paraguay,...
Meme Coins
Meme Coins Face Volatility as AI Spending Drives Market Sentiment
The surge in corporate artificial‑intelligence budgets, led by major tech firms, is reshaping risk appetite across the crypto space, and meme coins are feeling...
Meme Coins
NEAR positions itself as the preferred settlement layer for high speed AI agent transactions
In the rapidly evolving world of decentralized finance, the NEAR Protocol has announced a bold strategy to pivot its platform into the high‑velocity arena...
NFTs
Absci moves its AI‑driven cancer drug ABS‑201 into the first human trial phase
Absci Corporation, a pioneer in artificial intelligence-enabled drug discovery, has announced that its lead compound ABS‑201 has entered Phase I clinical trials. The milestone...
